Event Details
HER2 in NSCLC: What matters now? - Treatment, Testing & Sequencing
Date:
01 Sep 2026 at 7:00 PM to 8:30 PM
Join Prof Nicolas Girard (France), Prof Nick Pavlakis and Prof Jeremy Fox online to explore the evolving management of HER2-driven NSCLC and the rapidly changing landscape of precision thoracic oncology.
Review the latest evidence for HER2-targeted therapies, practical approaches to molecular testing and interpretation, and contemporary strategies for treatment selection, sequencing and multidisciplinary care.
Through expert presentations, practical case discussions and an interactive Q&A, this session will provide actionable insights to support the translation of emerging evidence into everyday Australian oncology practice.
Register
The Royal Australasian College of Physicians publishes notices of events as a service to members. Such publication does not constitute endorsement or mandating of the event.